DMK PHARMACEUTICALS CORPORATION Finite-Lived Intangible Assets, Net
DMK PHARMACEUTICALS CORPORATION had Finite-Lived Intangible Assets, Net of $4.56 million as of 2021-06-30, per its 10-Q filed 2021-11-22.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2021-11-22
- 2021-06-30: Finite-Lived Intangible Assets, Net $4.56M.
- 2021-03-31: Finite-Lived Intangible Assets, Net $4.80M.
- 2020-12-31: Finite-Lived Intangible Assets, Net $5.04M.
- 2020-09-30: Finite-Lived Intangible Assets, Net $8.43M.
| Period end | Finite-Lived Intangible Assets, Net |
|---|---|
| 2021-06-30 | $4.56M 10-Q · filed 2021-11-22 |
| 2021-03-31 | $4.80M 10-Q · filed 2021-11-22 |
| 2020-12-31 | $5.04M 10-Q · filed 2021-11-22 |
| 2020-09-30 | $8.43M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $8.91M 10-Q · filed 2020-08-17 |
| 2020-03-31 | $9.39M 10-Q · filed 2020-05-18 |
| 2019-12-31 | $9.87M 10-K · filed 2021-04-15 |
| 2019-09-30 | $10.36M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $10.85M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $11.34M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $11.96M 10-K · filed 2020-03-30 |
| 2018-09-30 | $12.57M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $13.19M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $13.81M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $14.43M 10-K · filed 2019-03-15 |
| 2017-09-30 | $15.05M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $15.67M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $16.29M 10-Q · filed 2017-05-12 |
| 2016-12-31 | $16.89M 10-K · filed 2018-03-16 |
| 2016-09-30 | $17.51M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $18.13M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $7.52M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $7.77M 10-Q · filed 2016-05-13 |
| 2015-09-30 | $8.01M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $8.25M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $8.50M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $8.74M 10-K · filed 2016-03-23 |
| 2014-09-30 | $9.03M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $9.32M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $9.61M 10-KT · filed 2015-03-26 |